Research Updates
A new edition of the “Caring for People with A-T” guide has been published!
MoreWe are pleased to announce that funds have been awarded to a researcher with Johns Hopkins University.
MoreWe’re feeling so optimistic about the new year, given the accelerated progress we’re seeing in our search for therapies—and ultimately, a cure—for ataxia-telangiectasia (A-T)!
MoreWe’re thrilled to share encouraging initial results from a study funded by the A-T Children’s Project and conducted by Charles River Laboratories.
MoreThe Jeff Jehlik Memorial Fund Will Match Your “Giving Tuesday” Donation for A-T up to $100,000!
MoreThe A-T Children’s Project has available funds for a grant to test gene editing technologies to restore ATM protein function in cells from children with ataxia-telangiectasia.
MoreThe A-TCP is hosting an international Gene Therapy for A-T conference in November.
MoreQuince Therapeutics is advancing a phase 3 clinical trial to evaluate EryDex, a potential new treatment for ataxia-telangiectasia (A-T).
MoreOn December 18, the A-T Children’s Project sent out the below email to A-T parents in the United States inviting their children with and without A-T to participate in the A-T Biomarker Development Initiative. THE A-T BIOMARKER DEVELOPMENT INITIATIVE Join us in identifying desperately needed biomarkers to improve the development…
MoreIt’s Giving Tuesday, and anonymous donors have joined together to match the first $60,000 in donations we receive! Please donate today to take advantage of this match and to help us keep our momentum as we head into 2024.
More